Use of a cannabinoid receptor agonist or a pharmaceutically acceptable salt or an optical isomer thereof, and methods for the inhibition of transient lower esophageal sphincter relaxation, treatment of gastroesophageal reflux disease, prevention of reflux, treatment or prevention of regurgitation, lung disease, asthma and chronic laryngitis and to control developmental failure

摘要

"USE OF A CANABINOID RECEPTOR AGONIST OR PHARMACEUTICALLY ACCEPTABLE SALT OR OPTIC ISEMER OF THE SAME, AND METHODS FOR INHIBITION OF TRANSITIONAL SPHERIC RELAXATIONS, INFLAMENTAL TREFLAGE TREATOUS TRAFFLE OR PREVENTION OF REGURGITATION, LUNG DISEASE, ASTHMA AND CHRONIC LARYNGITIS AND TO CONTROL DEVELOPMENT INSUFFICIENCY ". The present invention relates to the use of cannabinoid receptor agonists for the inhibition of transient lower esophageal sphincter relaxations. Another aspect of the invention is directed to the use of cannabinoid receptor agonists for the treatment of gastroesophageal reflux disease as well as for the treatment of regurgitation such as regurgitation in children, lung disease, chronic laryngitis and asthma.